ArticleCancer research communications2026

Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo.

Jasmin Traichel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.